Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00278824
Recruitment Status : Terminated (Difficulty identifying and enrolling eligible patients)
First Posted : January 18, 2006
Last Update Posted : June 5, 2012
Information provided by (Responsible Party):
ZARS Pharma Inc.

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 2006
  Actual Study Completion Date : August 2006